ACTHERA THERAPEUTICS
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
ACTHERA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2019-10-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.acthera-therapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
7.6 M CHF
Technology used in webpage:
Euro Swiss Server Location
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Hyris
Hyris is offers an integrated platform for decentralized nucleic acid testing Products.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Latch Medical
Latch Medical reimagining the potential of drugs and vaccines.
Novasenta
Novasenta develops treatments to transform the lives of patients with cancer.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2022-06-01
Current Employees Featured
Thierry Fumeaux CEO @ Acthera Therapeutics
CEO
2021-04-01
Pierre-Alain Monnard CSO @ Acthera Therapeutics
CSO
Cyrille Maugeais CTSO @ Acthera Therapeutics
CTSO
2019-12-01
Andreas Zumbühl CSO @ Acthera Therapeutics
CSO
Yannick Schmid Senior scientist @ Acthera Therapeutics
Senior scientist
2021-01-01
Bernadine Wermelinger Office Manager @ Acthera Therapeutics
Office Manager
2021-09-01
Patrick Schacher CFO @ Acthera Therapeutics
CFO
Franziska Richner Scientist @ Acthera Therapeutics
Scientist
2022-04-01
Miljenko Panajatovic Scientist @ Acthera Therapeutics
Scientist
2021-08-01
Founder
Investors List
IMD Startup Competition
IMD Startup Competition investment in Grant - Acthera Therapeutics
Official Site Inspections
http://www.acthera-therapeutics.com
- Host name: 172.67.147.168
- IP address: 172.67.147.168
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acthera Therapeutics"
Acthera Therapeutics 2025 Company Profile: Valuation, Funding ...
Acthera Therapeutics was founded in 2019. Where is Acthera Therapeutics headquartered? Acthera Therapeutics is headquartered in Basel, Switzerland. What is the size of Acthera …See details»
Acthera – Unleashing the Power of Mechanosensitive …
Mar 18, 2022 To fully unleash the power of mechanosensitive, actuated therapeutics, the biotech start-up Acthera Therapeutics Ltd. was launched in Fall 2019. The company unites talents from the field of basic and applied liposome …See details»
Acthera Therapeutics - Funding, Financials, Valuation & Investors
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery. New. Resources. Advanced Search. ... How much …See details»
Acthera Therapeutics Ltd - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Acthera Therapeutics is a …See details»
Acthera Therapeutics Ltd. | LinkedIn - LinkedIn Schweiz
Acthera Therapeutics Ltd. | 1.419 Follower:innen auf LinkedIn. ACTHERA is currently in liquidation, and was a Swiss biotech company founded in 2019. The team was developing a …See details»
Acthera Therapeutics AG - startup.ch
Acthera Therapeutics AG: Today, patients are exposed to unwanted side effects of drugs. With the use of our technology, we can control and target the delivery of drugs with an adaptable and versatile system built around the Hard-Shelled …See details»
Acthera Therapeutics AG - VentureRadar
Website: https://acthera-therapeutics.com. Develops mechano-responsive hard-shelled liposomes for targeted, controlled delivery of therapeutic agents, improving efficacy, safety, and efficiency …See details»
Acthera Therapeutics - Company Profile - Tracxn
Feb 26, 2025 Acthera Therapeutics - Provider of research, development, and manufacturing services for small molecule drugs. Raised a total funding of $5.83M over 1 round from 1 …See details»
Acthera Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Acthera Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Acthera Therapeutics - Contacts, Employees, Board Members
Acthera Therapeutics has 9 current employee profiles, including CEO Thierry Fumeaux. Acthera Therapeutics has 4 board members and advisors, including Roger Meier . ContactsSee details»
Acthera Therapeutics AG - Drug pipelines, Patents, Clinical
100 Translational Medicine associated with Acthera Therapeutics AG. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full …See details»
Acthera Therapeutics Ltd at the Swiss Biotech Day
Acthera Therapeutics is developing a unique type of mechano-sensitive Hard-Shelled Liposomes (HSL), based on a patented synthetic lipid. The HSL release their payload when submitted to a …See details»
Acthera Therapeutics - Overview, News & Similar companies
Some of the popular technologies that Acthera Therapeutics uses are: Microsoft Exchange Online, Microsoft 365 What does Acthera Therapeutics do? Acthera Therapeutics Ltd is a …See details»
Acthera Therapeutics - Products, Competitors, Financials, …
Acthera Therapeutics is a biopharmaceutical company that focuses on the development of nanoparticle-based technology for targeted and controlled drug delivery. The company's main …See details»
45 % of oncology patients suffer fromsevere drug toxicities 5 % of ...
Acthera Therapeutics is a preclinical-stage biopharma-ceutical company. It develops hard-shelled liposomes, a nanoparticle-based technology for the targeted and ... Acthera’s Hard-Shelled …See details»
Acthera Therapeutics AG in Liq. - Zefix
Acthera Therapeutics AG, in Basel, CHE-328.740.542, Aktiengesellschaft (SHAB Nr. 199 vom 13.10.2023, Publ. 1005860151). Firma neu: Acthera Therapeutics AG in Liq.. Vinkulierung …See details»
Acthera receives CHF 5.4 million to advance hard-shelled liposome ...
Jul 23, 2021 Acthera Therapeutics AG, a biopharmaceutical company developing an innovative targeted release technology platform, announced today the successful completion of a CHF …See details»
ACTHERA Tx closes Seed A financing and strengthens team to …
Jul 6, 2021 Acthera Therapeutics AG, a biopharmaceutical company developing an innovative targeted release technology platform, announced today the successful completion of a CHF …See details»
Acthera Therapeutics raises CHF 5.4 million seed capital
Feb 7, 2021 Founded in 2019, Acthera Therapeutics addresses one of the most important challenges in medicine, optimizing the therapeutic effect while minimizing the side effects. …See details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to …
18 hours ago Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing product developmentSee details»